Lantern Pharma Inc.

LTRN

0 Followers
$3.86 -10.94% -$0.48
6 August
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

Lantern Pharma Inc. is a biotechnology company focused on developing personalized therapeutic approaches for cancer patients. The company utilizes advanced bioinformatics and artificial intelligence to identify genetic and molecular characteristics of cancer tumors, enabling better targeting of therapeutic strategies for individual patients. Lantern Pharma focuses on discovering and developing new drugs and combination therapies that could be effective in patients with various types of cancer, including those who have not been successfully treated by standard methods. The goal of Lantern Pharma is to bring innovative treatment approaches and improve treatment outcomes for cancer patients.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade